Clinical Trial Update: SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for SB-715992 in locally advanced, recurrent, or metastatic liver cancer has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• SB-715992

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED